These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32578579)

  • 41. Quality standard for the management of patients with psoriatic arthritis: QUANTUM Project.
    Sanz Sanz J; Beltrán E; Díaz-Miguel Pérez MC; Fernández-Carballido C; Galíndez E; García Porrua C; Gratacós J; Medina J; Queiro R; Ramírez J; Reina D; Rodríguez Lozano C; Rodríguez Martínez FJ; Rubio E; Veroz R
    Reumatol Clin (Engl Ed); 2020; 16(3):203-215. PubMed ID: 30054254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
    González-Álvaro I; Martínez-Fernández C; Dorantes-Calderón B; García-Vicuña R; Hernández-Cruz B; Herrero-Ambrosio A; Ibarra-Barrueta O; Martín-Mola E; Monte-Boquet E; Morell-Baladrón A; Sanmartí R; Sanz-Sanz J; de Toro-Santos FJ; Vela P; Román Ivorra JA; Poveda-Andrés JL; Muñoz-Fernández S; ;
    Rheumatology (Oxford); 2015 Jul; 54(7):1200-9. PubMed ID: 25526976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of outcome in psoriatic arthritis.
    Taylor WJ
    Curr Opin Rheumatol; 2004 Jul; 16(4):350-6. PubMed ID: 15201596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods.
    Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii110-2. PubMed ID: 15708923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitors.
    Tsuruta N; Narisawa Y; Imafuku S; Ito K; Yamaguchi K; Miyagi T; Takahashi K; Fukamatsu H; Morizane S; Koketsu H; Yamaguchi M; Hino R; Nakamura M; Ohyama B; Ohata C; Kuwashiro M; Sato T; Saito K; Kaneko S; Yonekura K; Hayashi H; Yanase T; Morimoto K; Sugita K; Yanagihara S; Kikuchi S; Mitoma C; Nakahara T; Furue M; Okazaki F
    J Dermatol; 2019 Mar; 46(3):193-198. PubMed ID: 30628100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Singapore chapter of rheumatologists' updated consensus statement on the eligibility for government subsidization of biologic and targeted therapy for the treatment of psoriatic arthritis.
    Chua CKT; Teng GG; Cheung PP; Fong WWS; Leong KH; Leung YY; Lim AYN; Lui NL; Manghani M; Santosa A; Sriranganathan MK; Suresh E; Tan TC; Lahiri M
    Int J Rheum Dis; 2020 Feb; 23(2):153-164. PubMed ID: 31762214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
    Baum EW; Schwartzman S
    Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion.
    Lavie F; Salliot C; Dernis E; Claudepierre P; Schaeverbeke T; Tebib J; Goupille P; Cantagrel A; Flipo RM; Gaudin P; Le Loët X; Maillefert JF; Paul C; Saraux A; Wendling D; Combe B
    Joint Bone Spine; 2009 Oct; 76(5):540-6. PubMed ID: 19457693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritis.
    Zabotti A; Sakellariou G; Tinazzi I; Idolazzi L; Batticciotto A; Canzoni M; Carrara G; De Lucia O; Figus F; Girolimetto N; Macchioni P; McConnell R; Possemato N; Iagnocco A
    Ann Rheum Dis; 2020 Aug; 79(8):1037-1043. PubMed ID: 32430315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axial involvement in psoriatic arthritis: An update for rheumatologists.
    Poddubnyy D; Jadon DR; Van den Bosch F; Mease PJ; Gladman DD
    Semin Arthritis Rheum; 2021 Aug; 51(4):880-887. PubMed ID: 34198146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definition of Remission and Disease Activity Assessment in Psoriatic Arthritis: Evidence and Expert-Based Recommendations.
    Almodóvar R; Cañete JD; de Miguel E; Pinto JA; Queiro R
    Reumatol Clin (Engl Ed); 2021; 17(6):343-350. PubMed ID: 31859154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psoriatic arthritis.
    López-Ferrer A; Laiz A; Puig L
    Med Clin (Barc); 2022 Jul; 159(1):40-46. PubMed ID: 35525675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centers.
    Messina F; Valenti M; Malagoli P; Dattola A; Gisondi P; Burlando M; Dapavo P; Dini V; Franchi C; Loconsole F; Megna M; Costanzo A
    Ital J Dermatol Venerol; 2022 Jun; 157(3):231-234. PubMed ID: 35005856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists.
    Boehncke WH; Anliker MD; Conrad C; Dudler J; Hasler F; Hasler P; Häusermann P; Kyburz D; Laffitte E; Michel BA; Möller B; Navarini AA; Villiger PM; Yawalkar N; Gabay C
    Dermatology; 2015; 230(1):75-81. PubMed ID: 25573238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the impact of psoriatic arthritis on patient function and quality of life: lessons learned from other rheumatologic conditions.
    Mease PJ
    Semin Arthritis Rheum; 2009 Feb; 38(4):320-35. PubMed ID: 18304610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study.
    Giacomelli R; Gorla R; Trotta F; Tirri R; Grassi W; Bazzichi L; Galeazzi M; Matucci-Cerinic M; Scarpa R; Cantini F; Gerli R; Lapadula G; Sinigaglia L; Ferraccioli G; Olivieri I; Ruscitti P; Sarzi-Puttini P
    Rheumatology (Oxford); 2015 May; 54(5):792-7. PubMed ID: 25288786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.
    Harrold LR; Stolshek BS; Rebello S; Collier DH; Mutebi A; Wade SW; Malley W; Greenberg JD; Etzel CJ
    Clin Rheumatol; 2017 Apr; 36(4):895-901. PubMed ID: 28271234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project.
    Almodovar R; Torre Alonso JC; Batlle E; Castillo C; Collantes-Estevez E; de Miguel E; González S; Gratacós J; Hernández A; Juanola X; Linares LF; Moreno MJ; Moreno M; Navarro-Compán V; Rodríguez Lozano C; Sanz J; Sellas A; Loza E; Zarco P;
    Reumatol Clin (Engl Ed); 2018; 14(3):155-159. PubMed ID: 28284772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.